• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 274

Substance: Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis
Intended Use: As an enzyme in the starch industry to obtain dextrins with improved physical properties, such as higher solubility, lower viscosity, and reduced retrogradation
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
77 Perry Chapel Church Rd.
Box 576
Franklinton, NC  27525
Date of filing: Dec 30, 2008
GRAS Notice (releasable information): 274
Date of closure / FDA's Letter: Jun 25, 2009
FDA has no questions